The long-overlooked molecule that will define a generation of science
May 29, 2024
Industry news
Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)
AReNA shines at BIO 2025
AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention
Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector
DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader
MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.
D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress
AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal
Panagiotis Prinos appointed as Director of Réseau DePTAQ
The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.
CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM
Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke
Two panelists represent AReNA at Leyton Connect’s 5-to-7
AReNA attended FISQ
AReNA attends CASTL’s Open Door Day
Epitopea closes their $31 million pre-Series A financing.
Congratulations to the Nobel Prize winners in Medicine!
Congratulations to the 23 recipients of the D2R funding programs
The creation of training programs to meet the needs of the RNA therapeutics industry
The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies
A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec
Quebec Launches AReNA to Become a Global Leader in RNA Therapies